Skip to main content
Clinical Trials/NCT04171362
NCT04171362
Completed
Not Applicable

The Effect of Connective Tissue Massage in Patients With Migraine

Ankara Yildirim Beyazıt University1 site in 1 country16 target enrollmentMarch 28, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Migraine With Aura
Sponsor
Ankara Yildirim Beyazıt University
Enrollment
16
Locations
1
Primary Endpoint
Migraine Disability Assessment Test
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study was to investigate the effectiveness of connective tissue massage in patients with migraine

Registry
clinicaltrials.gov
Start Date
March 28, 2019
End Date
December 20, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ankara Yildirim Beyazıt University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of Migraine Disease
  • Being volunteer

Exclusion Criteria

  • Serious psychiatric problems with mental and / or communication problems Neurological, inflammatory or endocrine disease

Outcomes

Primary Outcomes

Migraine Disability Assessment Test

Time Frame: change from baseline at 4 weeks

To assess the level of disability of patients Migraine Disability Assessment Test (MIDAS) was used. It is a widely used and validated test. MIDAS was translated into Turkish and validity and reliability studies were conducted. MIDAS is a test filled in by patients that identifies migraine disability in all areas of activity during last 3 months.It consists of 5 questions.The total MIDAS score is the sum of the days given as response to these five questions (MIDAS 1 to MIDAS 5). The total score ranges from 0 to 90 and is used to categorize patients in disability grades I to IV. A higher score means more severe disability, placing the patient in a higher disability grade

Secondary Outcomes

  • Pittsburgh Sleep Quality Index(change from baseline at 4 weeks)
  • Hospital Anxiety and Depression Scale ((change from baseline at 4 weeks)
  • Nothingham Health Profile(Before the treatment and end of 4 weeks)
  • Allodynia Symptom Checklist(change from baseline at 4 weeks)

Study Sites (1)

Loading locations...

Similar Trials